Review of Commercially Available Epilepsy Genetic Panels

Journal of Genetic Counseling

Volumn 25, Issue 2, 2016, Pages 213-217

  Chambers, Chelsea ^a   Jansen, Laura A ^a   Dhamija, Radhika ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Epilepsy; Genetic counselling; Next generation sequencing

Indexed keywords

EPILEPSY; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; HUMAN; INFORMED CONSENT; PHENOTYPE;

EPILEPSY; GENETIC COUNSELING; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFORMED CONSENT; PHENOTYPE;

EID: 84961205280     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-015-9906-9     Document Type: Review

References (10)

1. de Koning, T. J., Jongbloed, J. D., Sikkema-Raddatz, B., & Sinke, R. J. (2014). Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges. Expert Review of Molecular Diagnostics. doi:10.1586/14737159.2015.976555. 1–10.
2. Green, R. C., Berg, J. S., Grody, W. W., et al. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine, 15(7), 565–574. doi:10.1038/gim.2013.73.
3. Kwan, P., Schachter, S. C., & Brodie, M. J. (2011). Drug-resistant epilepsy. New England Journal of Medicine, 365(10), 919–926. doi:10.1056/NEJMra1004418.
4. Ormond, K. E. (2013). From genetic counseling to “genomic counseling”. Molecular Genetics & Genomic Medicine, 1(4), 189–193. doi:10.1002/mgg3.45.
5. Parisi, P., Oliva, A., Coll Vidal, M., Partemi, S., Campuzano, O., & Brugada, R. (2013). Coexistence of epilepsy and brugada syndrome in a family with SCN5A mutation. Epilepsy Research, 105(3), 415–418. doi:10.1016/j.eplepsyres.2013.02.024.
6. Platt, J., Cox, R., & Enns, G. M. (2014). Points to consider in the clinical use of NGS panels for mitochondrial disease: an analysis of gene inclusion and consent forms. Journal of Genetic Counseling, 23(4), 594–603. doi:10.1007/s10897-013-9683-2.
7. Pong, A. W., Pal, D. K., & Chung, W. K. (2011). Developments in molecular genetic diagnostics: an update for the pediatric epilepsy specialist. Pediatric Neurology, 44(5), 317–327. doi:10.1016/j.pediatrneurol.2011.01.017.
8. Scheffer, I. E. (2014). Epilepsy genetics revolutionizes clinical practice. Neuropediatrics, 45(2), 70–74. doi:10.1055/s-0034-1371508.
9. Sweetman, L., Millington, D. S., Therrell, B. L., Hannon, W. H., Popovich, B., Watson, M. S., & van Dyck, P. C. (2006). Naming and counting disorders (conditions) included in newborn screening panels. Pediatrics, 117(5 Pt 2), S308–314. doi:10.1542/peds.2005-2633J.
10. Wang, J., Gotway, G., Pascual, J. M., & Park, J. Y. (2014). Diagnostic yield of clinical next-generation sequencing panels for epilepsy. JAMA Neurology, 71(5), 650–651. doi:10.1001/jamaneurol.2014.405.